Avid Bioservices Inc (CDMO) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Oct 31 2024 to Oct 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Avid Bioservices Inc   (NASDAQ: CDMO)


Avid Bioservices Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Avid Bioservices Inc's ROI in the second quarter of 2025?
Avid Bioservices Inc recorded a cumulative net loss of $-152 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -60.15%.

Within the Healthcare sector 606 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 2925 to 3861.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Oct 31 2024)
II. Quarter		 (Jul 31 2024)
I. Quarter		 (Apr 30 2024)
IV. Quarter		 (Jan 31 2024)
III. Quarter		 (Oct 31 2023)
II. Quarter
Y / Y Investment Change TTM -32.38 % -22.9 % -13.99 % -13.3 % 3.29 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 249 264 266 232 377
Return On Investment (TTM) -60.15 % -50.62 % -44.91 % -5.26 % -3.26 %
CDMO's Overall Ranking # 3861 # 2925 # 3015 # 2820 # 2860
Seq. Investment Change TTM -11.24 % -9.12 % -8.14 % -8.74 % 1.21 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -152 -144 -141 -18 -12

CDMO Company Profile >> Back to CDMO Roi Comparisons >> See Annual CDMO Return On Investment



Return On Investment CDMO's Ranking
Within: No.
Industry # 258
Sector # 607
Overall # 3861

Return On Investment Statistics
High Average Low
49.57 %
-31.98 %
-102.75 %
(Apr 30 2022)   (Dec. 30, 2015)



  News about Avid Bioservices Inc Return on Investment ROI

Avid Bioservices Faces Nasdaq Wrath for Late Filing, Stock Plummets Below Expectations

March 20, 2024

Avid Bioservices Faces Nasdaq Notice for Late Filing, As Stock Performs Below Expectations
TUSTIN, Calif., March 20, 2024 - Avid Bioservices, Inc. (Nasdaq: CDMO), a renowned biologics contract development and manufacturing organization (CDMO), landed in troubled waters as it recently received a deficiency notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq). The notice, delivered on March 19, 2024, informed Avid Bioservices that it was not in compliance with Nasdaq s continued listing requirements, specifically Nasdaq Listing Rule 5250(c)(1), due to its failure to file the Quarterly Report on Form 10-Q for the fiscal quarter ended January 31, 2024, within the given time frame.
Avid Bioservices, with its reputation for excellence in biologics contract development and manufacturing, is now grappling with the consequences of this non-compliance issue. The company s stock value has taken a significant hit, currently trading on the NASDAQ at a striking -43% below its 52-week average. This development has raised concerns among shareholders and investors alike, as Avid Bioservices strives to restore confidence by addressing the underlying deficiencies and complying with regulatory requirements.





Financial Statements
Avid Bioservices Inc's II. Quarter Investments $ 249 Millions CDMO's Balance sheet
Avid Bioservices Inc's II. Quarter Income $ -17 Millions Quarterly CDMO's Income Statement
CDMO's Income by Division See CDMO's Income by Division


CDMO Annual Return On Investment (Apr 30 2024)
2024		 (Apr 30 2023)
2023		 (Apr 30 2022)
2022		 (Apr 30 2021)
2021		 (Apr 30 2020)
2020
Total Investments in Millions 266 377 354 195 63
Y / Y Investment Growth -29.45 % 6.48 % 81.98 % 208.16 % 14.32 %
Net Income in Millions -141 0 128 11 -10
Y / Y Net Income Growth - -99.8 % 1038.71 % - -
Annual Return On Investment -52.92 % 0.07 % 36.06 % 5.76 % -16.58 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDMO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDMO's Competitors
Subscribers only: Roi for Avid Bioservices Inc's Suppliers
Subscribers only: Return On Investment for CDMO's Customers

Other Ratios
CDMO's Roa CDMO's Inventory Turnover Ratio CDMO's Growth Rates CDMO's Dividend Statistics
CDMO's Profitability Ratios CDMO's Asset Turnover Ratio CDMO's Dividend Growth
CDMO's Roe CDMO's Valuation Ratios CDMO's Financial Strength Ratios CDMO's Dividend Payout Ratio



Companies with similar Return On Investment at Oct 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.